(旧版)高血圧治療ガイドライン2004

 
文献
 
1 厚生統計協会:死因の概要.国民衛生の動向.厚生の指標(臨時増刊)2003; 50: 46-51.
2 上島弘嗣:日本の高血圧・世界の高血圧(2)国民の血圧低下と循環器疾患死亡率の減少.血圧 1994; 1: 194-201.
3 Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M: Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
4 Kitamura A, Iso H, Iida M, Naito Y, Sato S, Jacob DR, Nakamura M, Shimamoto T, Komachi Y: Trends in the indicence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med 2002; 112: 104-109.
5 厚生労働省大臣官房統計情報部(編集):平成14年度人口動態統計上巻.厚生統計協会,東京,2004.
6 磯村孝二:3指-1 地域ベースの長期フォローシステムの研究.平成5年度厚生省循環器病研究委託費による研究報告集,国立循環器病センター,1994.
7 Kimura Y, Takishita S, Muratani H, Kinjo K, Shinzato Y, Muratani A, Fukiyama K: Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan. Internal Med 1998; 37: 736-745.
8 Asia Pacific Cohort Studies Collaboration: Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707-716.
9 谷崎弓裕,清原裕,加藤功,岩本廣満,中山敬三,清水治樹,下野淳哉,山縣元,有馬久富,篠原規恭,近藤英樹,井林雪郎,藤島正敏:久山町の地域住民におけるJNC Ⅵの血圧分類とタイプ別脳梗塞発症率の関係-血圧レベルの時代的変化を考慮に入れた検討-.第21回日本高血圧学会総会プログラム抄録集,1998,p22.
10 NIPPON DATA80 Research Group: Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese. Nippon Data80. J Hum Hypertens 2003; 17: 851-857.
11 Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population. The Hisayama Study. Stroke 2000; 31: 2616-2622.
12 健康日本21企画検討会,計画策定検討会報告書:健康日本21(21世紀における国民健康づくり運動について).健康・体力づくり事業財団,東京,2000.
13 Arima H, Tanizaki Y, Kiyohara Y, Tsuchihashi T, Kato I, Kubo M, Tanaka K, Ohkubo K, Nakamura H, Abe I, Fujishima M, Iida M: Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly. The Hisayama Study. Arch Intern Med 2003; 163: 361-366.
14 Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
15 Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M; for the WHO MONICA Project: Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke 1995; 26: 361-367.
16 Kita Y, Okayama A, Ueshima H, Wada M, Nozaki A, Choudhury SR, Bonita R, Inamoto Y, Kasamatsu T: Stroke incidence and case fatality in Shiga, Japan. 1989-1993. Int J Epidemiol 1999; 28: 1059-1065.
17 Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319-329.
18 Nakagawa H, Morikawa Y, Okayama A, Fujita Y, Yoshida Y, Mikawa K, Sakata K, Ishizaki M, Miura K, Naruse Y, Kagamimori S, Hashimoto T, Ueshima H: Trends in blood pressure and urinary sodium and potassium excretion in Japan: reinvestigation in the 8th year after the Intersalt study. J Hum Hypertens 1999; 13: 735-741.
19 Stamler J: INTERMAP. Special Issue. J Hum Hypertens 2003; 17: 587-775.
20 上島弘嗣:青壮年者を対象とした生活習慣病予防のための長期介入研究.平成12年度総括・分担研究報告書,2001.
21 児島三郎,船木章悦,沢部光一,高桑克子:昭和20年代後半から昭和30年代後半までの実態.循環器疾患の変貌.小町喜男,磯村孝二,児島三郎,嶋本喬,田中平三,小澤秀樹(編集),保健同人社,東京,1987, pp120-138.
22 Intersalt Cooperative Research Group: INTERSALT. Appendix tables. J Hum Hypertens 1989; 3: 331-407.
23 Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension(DASH)diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
24 循環器病予防研究会:第5次循環器疾患基礎調査結果.中央法規出版,東京,2002.
25 厚生省公衆衛生局:昭和55年循環器疾患基礎調査報告.日本心臓財団,1982.
26 厚生省公衆衛生局:第4次循環器疾患基礎調査(平成2年)報告.循環器病研究振興財団および日本循環器病研究管理協議会,1993.
27 Hozawa A, Ohkubo T, Kikuya M, Yamaguchi J, Ohmori K, Fujiwara T, Hashimoto J, Matsubara M, Kitaoka H, Nagai K, Tsuji I, Satoh H, Hisamichi S, Imai Y: Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res 2002; 25: 57-63.
28 大久保孝義,小原拓,舟橋仁,菊谷昌浩,橋本潤一郎,今井潤:家庭血圧コントロール状況に関する全国調査研究(J-HOME研究)中間報告.2003年4月末における対象患者1533人の家庭血圧状況.Ther Res 2003; 24: 1849-1855.
29 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: the National High Blood Pressure Education Program Coordination Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572.
30 Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M: INTERSALT study findings. Public health and medical care implications. Hypertension 1989; 14: 570-577.
31 常松典子,上島弘嗣,奥田奈賀子,由田克士,岡山明,斎藤重幸,坂田清美,岡村智教,ソヘル・レザ・チュウドリ,門脇崇,喜多義邦,中川秀昭,INTERMAP日本研究班:減塩食実施者は通常の食生活の人に比べ食塩摂取量がどの程度少ないか?-INTERMAP日本より.日循予防誌 2004; 39: 149-155.
32 Smits P, Thien T, Van't Laar A: The cardiovascular effects of regular and decaffeinated coffee. Br J Clin Pharmacol 1985; 19: 852-854.
33 Minami J, Ishimitsu T, Matsuoka H: Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999; 33: 586-590.
34 Prisant LM, Alpert BS, Robbins CB, Berson AS, Hayes M, Cohen ML, Sheps SG: American National Standard for Nonautomated Sphygmomanometers summary report. Am J Hypertens 1995; 8: 210-213.
35 Menard J, Chatellier G, Day M, Vaur L: Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio. J Hypertens 1994; 12: S21-S25.
36 Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K, on Behalf of the Japanese Society of Hypertension: Japanese Society of Hypertension(JSH)guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771-782.
37 Imai Y, Munakata M, Yoshino H, Watanabe N, Onodera N, Kato J, Satoh H, Sekino H, Abe K: Seasonal variation in blood pressure in normotensive subjects studied by home measurements. Clin Sci 1996; 95: 55-60.
38 Kikuya M, Chonan K, Imai Y, Goto E, Ishii M: Research group to assess the validity of automated blood pressure measurement devices in Japan: Accuracy and reliability of wrist-cuff devices for self-measurement of blood pressure. J Hypertens 2002; 20: 629-638.
39 石光俊彦,松岡博昭,南順一,河野雄平:高血圧診療における家庭用自動血圧計の有用性に関する検討.Ther Res 1997; 18: 488-493.
40 石井當男,後藤英司:家庭血圧計の精度管理.Ther Res 1998; 19: 56-59.
41 Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S: Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-975.
42 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
43 Guideline Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
44 Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
45 Tsuji I, Imai Y, Nagai K, Ohkubo T, Watanabe N, Minami N: Proposal of reference values for home blood pressure measurement. Prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. Am J Hypertens 1997; 10: 409-419.
46 Imai Y, Ohkubo T, Tsuji I, Nagai K, Satoh H, Hisamichi S, Abe K: Prognostic value of ambulatory and home blood pressure measurements in comparison to screening blood pressure measurements: a pilot study in Ohasama. Blood Press Monit 1996; 1(Suppl 2): S51-S58.
47 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2000年版.日本高血圧学会,東京,2000.
48 Fujiwara T, Nishimura T, Ohkubo T, Imai Y: Rationale and design of HOMED-BP study: Hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Press Monit 2002; 7: 77-82.
49 Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Sekino H, Nihei M, Yoshinaga K: Determination of clinical accuracy and nocturnal blood pressure pattern by new portable device for monitoring indirect ambulatory blood pressure. Am J Hypertens 1990; 3: 293-301.
50 Imai Y, Sasaki S, Minami N, Munakata M, Hashimoto J, Sakuma H, Sakuma M, Watanabe N, Imai K, Sekino H, Abe K: The accuracy and performance of the A & D TM2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719-726.
51 Kuwajima I, Nishinaga M, Kanamaru A: The accuracy and clinical performance of a new compact ambulatory blood pressure monitoring device, the ES-H531. Am J Hypertens 1998; 11: 1328-1333.
52 島田和幸,今井潤,桑島巌,栃久保修,林博史,河野雄平,川崎晃一:24時間血圧計の使用(ABPM)基準に関するガイドライン.Jpn Circ J 2000; 64(Suppl 5): 1207-1248.
53 Sokolow M, Werdegar D, Kain HK, Hinman AT: Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966; 34: 279-298.
54 Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464-1470.
55 Imai Y, Ohkubo T, Sakuma M, Tsuji I, Nagai K, Satoh H, Hisamichi S, Abe K: Predictive power of screening BP, ambulatory BP and BP measured at home for overall cardiovascular mortality: A prospective observation in a cohort of northern Japan, Ohasama. Blood Press Monit 1996; 1: 251-254.
56 Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y: Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18: 847-854.
57 Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C: Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001; 103: 2579-2584.
58 Suzuki Y, Kuwajima I, Aono T, Kanemaru A, Nishinaga M, Shibata H, Ozawa T: Prognostic value of nighttime blood pressure in the elderly: a prospective study of 24-hour blood pressure. Hypertens Res 2000; 23: 323-330.
59 Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282: 539-546.
60 Shimada K, Kawamoto A, Matsubayashi K, Ozawa T: Silent cerebrovascular disease in the elderly. Correlation with ambulatory blood pressure. Hypertension 1990; 16: 692-699.
61 Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C: Circadian blood pressure and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
62 Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23-29.
63 Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Rebold G: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
64 Shimada K, Imai Y, Kuwajima I, Abe K: Patients characteristics and effects of the long-term acting calcium channel blocker barnidipine on circadian blood pressure changes: results of the Japanese Multicenter Study on Barnidipine with Ambulatory Blood Pressure Monitoring. Blood Press Monit 2001; 6(Suppl 2): S25-S30.
65 Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-hour blood pressure: the Ohasama study. J Hypertens 2002; 20: 1-7.
66 Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K: Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
67 Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Sakuma M, Satoh H, Hisamichi S, Abe K: Relation between nocturnal decline in blood pressure and mortality: The Ohasama Study. Am J Hypertens 1997; 10: 1201-1207.
68 Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, Hozawa A, Matsubara M, Suzuki M, Fujiwara T, Araki T, Satoh H, Hisamichi S, Imai Y: Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: The Ohasama Study. Clin Exp Hypertens 2002; 24: 261-275.
69 Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406.
70 川崎晃一,上園慶子:臨床的に健常な日本人の血圧日内変動の基準値設定の試み.血圧モニタリングの臨床,尾前照雄(監修),川崎晃一(編集),医学書院,東京,1993, pp181-189.
71 Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S: Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998; 32: 255-259.
72 Kikuya M, Hozawa A, Ohkubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y: Prognostic significance of blood pressure and heart rate variabilities. Hypertension 2000; 36: 901-906.
73 World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization(WHO)/International Society of Hypertension(ISH)statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
74 Ueda K, Omae T, Hasuo Y, Kiyohara Y, Fujii I, Wada J, Kato I, Kawano H, Shinkawa A, Omura T, Fujishima M: Prognosis and outcome of elderly hypertensives in a Japanese community: results from a long-term prospective study. J Hypertens 1988; 6: 991-997.
75 島本和明:高血圧管理・治療の新しい動向(JNC-VIとわが国の現状).日内会誌 1999; 88: 401-405.
76 Kassai B, Gueyffier F, Boissed J-P, Boutitie F, Cucherat M: Absolute benefit, number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit? J Clin Epidemiol 2003; 56: 977-982.
77 Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Yoshitake T: Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996; 45(Suppl 3): S14-S16.
78 日本透析医学会統計調査委員会:わが国の慢性透析療法の現況(2001年12月31日現在).日透析医学会誌 2003; 36: 1-31.
79 Hansson L, Zanchetti A, Carruthers SG, Dahl喃 B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT)randomised trial. Lancet 1998; 351: 1755-1762.
80 UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
81 Schrier RW, Estacio RO, Esler A, Mehler P: Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and stroke. Kidney Int 2002; 61: 1086-1097.
82 Omata K, Kanazawa M, Sato T, Abe F, Saito T, Abe K: Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease. Kidney Int 1996; 49(Suppl 55): S57-S62.
83 Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
84 Turner R, Holman R, Stratton I, Cull C, Frighi V, Manley S, Matthews D, Neil A, McElroy H, Kohner E, Fox C, Hadden D, Wright D: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 30. BMJ 1998; 317: 703-712.
85 Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999; 100: 354-360.
86 Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG: Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Cardiol 2002; 39: 52-54.
87 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
88 Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219.
89 O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
90 Safar ME, Levy BI, Struijker-Boudier H: Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
91 Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733.
92 Lever AF, Ramsey LE: Treatment of hypertension in the elderly. J Hypertens 1995; 13: 571-579.
93 Moser M, Hebert PR: Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
94 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD: Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic reviews and meta-analysis. JAMA 1997; 277: 739-745.
95 Collins R, Peto R: Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Textbook of Hypertension. Edited by Swales JD, Blackwell Scientific Publication, London, 1994, pp1156-1164.
96 Whelton PK, He J: Blood pressure reduction. In: Clinical Trials in Cardiovascular Disease: A Companion to Braunwald's Heart Disease. Edited by Hennekens CH, WB Saunders, Philadelphia, 1999, pp341-359.
97 Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-839.
98 厚生統計協会:国民衛生の動向.2003; 50: 412-413.
99 Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-872.
100 Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E: Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. Results from a meta-analysis of individual patient data in randomized controlled trials. Ann Intern Med 1997; 126: 761-767.
 
ページトップへ

ガイドライン解説

close-ico
カテゴリで探す
五十音で探す

診療ガイドライン検索

close-ico
カテゴリで探す
五十音で探す